Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma.

Antonio FarinaManon EscalereMatthias DionMartin MoussyAntoine PegatMacarena Villagrán-GarcíaPerrine DevicAnaïde LamiralAntoine SeyveKarine AureAdrien WangLucas GorzaNathalie StreichenbergerThierry MaisonobeJerome HonnoratCristina BirzuDimitri PsimarasDavid Weisenburger-LileBastien Joubert

Published in: Frontiers in neurology (2024)

We report the occurrence of mononeuritis multiplex, a very rare adverse event of immune checkpoint inhibitors, in the three patients with mesothelioma. Clinicians must be aware of this severe, yet treatable adverse event.

Keyphrases

real time pcr
high throughput
risk assessment
palliative care
early onset
adverse drug